March 13, 2018

 

Securities and Exchange Commission

100 F Street N.E.

Washington, DC 20549

 

We have read Item 4.01 of Form 8-K dated March 13, 2018, of AxoGen, Inc. and are in agreement with the statements made in response to that Item insofar as they related to our Firm.

 

Very truly yours,

 

/s/Lurie, LLP

 

Lurie, LLP